Lyme borreliosis: A tick-borne spirochaetal disease

Reviews and Research in Medical Microbiology

Volumn 9, Issue 2, 1998, Pages 99-107

  Hubbard, M J ^a   Cann, K J ^a,b   Baker, A S ^a  

^a DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^b Richards Building   (United Kingdom)

Author keywords

Borrelia burgdorferi; Lyme borreliosis; Spirochaete; Tick borne; Zoonosis

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; MINOCYCLINE; PENICILLIN G; PROBENECID; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; CHRONIC ARTHRITIS; CLINICAL FEATURE; DISEASE CARRIER; ECOLOGY; ERYTHEMA CHRONICUM MIGRANS; HEART DISEASE; LABORATORY DIAGNOSIS; LYME DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPIROCHETE; SYNOVECTOMY; TAXONOMY; TICK BITE; TICK BORNE DISEASE; UNITED STATES;

EID: 0031891704     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199804000-00004     Document Type: Article

References (69)

1. Buchwald A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Arch Dermatol Syph 1883; 15: 553-556.
2. Gruneberg T. Auffallige serologische befunde bei acrodermatitis chronica atrophicans heixheimer. Klin Wochenschr 1954; 32: 935-936.
3. Afzelius A. Erythema chronicum migrans. Acta Derm Venereol (Stockh) 1921; 2: 120-125.
4. Hellerstrom S. Erythema chronicum migrans Afzelius with meningitis. South Med J 1950; 43: 330-334.
5. Binder E, Doepfmer R, Hornstein O. Experimentelle Ubertragung des Erythema chronicum migrans von Mensch zu Mensch. Hautarzt 1955; 6: 494-496.
6. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davies JP. Lyme disease, a tick-borne spirochaetosis? Science 1982; 216: 1317-1319.
7. Miller GL, Craven RB, Bailey RE, Tsai TF. The epidemiology of Lyme disease in the United States. Lab Med 1990; 21: 285-289.
8. Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon 1922; 3: 765-767 [translation: Clin Infect Dis 1993; 16: 168-169].
9. Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon 1922; 3: 765-767 [translation: Clin Infect Dis 1993; 16: 168-169].
10. Bannwarth A. Zur Klinik und Pathogenese der 'chronischen lymphocytaren Meningitis'. Arch Psychiatr Nervenkr 1944; 117: 161-185.
11. Steere AC. Diagnosis and treatment of Lyme arthritis. Med Clin N Amer 1997; 81: 179-194.
12. Barbour AG, Burgdorfer W, Hayes SF, Peter O, Aeschlimann A. Isolation of a cultivable spirochaete from Ixodes ricinus ticks in Switzerland. Curr Microbiol 1983; 8: 123-126.
13. Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG. Borrelia burgdorferi sp. nov.: etiological agent of Lyme disease. Int J Syst Bacteriol 1984; 34: 496-497.
14. Azuluy RD, Azulayabulafia L, Sodre CT, Azulay DR, Azulay MM. Lyme disease in Rio de Janeiro, Brazil. Int J Dermatol 1991; 30: 569-571.
15. Nakao M, Miyamoto K, Fukanaga M. Lyme disease spirochaetes in Japan: enzootic transmission cycles in birds, rodents and Ixodes persulcatus ticks. J Infect Dis 1994; 170: 878-882.
16. Barry RD, Hudson BJ, Shafren DR, Wills MC. Lyme borreliosis in Australia, In: Axford JS, Rees DHE, eds. Lyme borreliosis. New York, London: Plenum Press, 1994.
17. Mhalu FS, Matre R. Serological evidence of Lyme borreliosis in Africa: results from studies in Dar es Salaam, Tanzania. E Afr Med J 1996; 73: 583-585.
18. Zhang P, Xu R, Chen Z, Zhang J, Cao W, Zhang Q. Detection of Borrelia burgdorferi DNA by PCR in potential tick vectors of China. Syst App Acarol 1997; 2: 43-46.
19. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988; 1: 399-414.
20. Hubbard MJ, Baker AS, Cann KJ. Distribution of Borrelia burgdorferi s.l. spirochaete DNA in British ticks (Argasidae and Ixodidae) since the 19th century, assessed by PCR. Med Vet Entomol (in press).
21. Oliver JH Jr. Lyme borreliosis in the southern United States: a review. J Parasitol 1996; 82: 926-935.
22. Balmelli T, Piffaretri JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995; 146: 329-340.
23. Berger BW, Kaplan MH, Rothenberg IR, Barbour AG. Isolation and characterisation of the Lyme disease spirochaete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol 1985; 13: 444-449.
24. Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: demonstration of spirochaetes in the myocardium. Ann Litern Med 1985; 103: 374-376.
25. Duray PH, Asbrink E, Weber E. The cutaneous manifestations of human Lyme disease: a widening spectrum. Adv Dermatol 1989; 4: 255-276.
26. Cooke WD, Dattwyler RJ. Complications of Lyme borreliosis. Annu Rev Med 1992; 43: 93-103.
27. Stanek G, Wewalka G, Groh V, Neumann R, Kristoferitsch M. Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet 1985; 325: 401.
28. Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann NY Acad Sci 1988; 539: 65-79.
29. Wokke JHJ, van Gijn J, Elderson A. Chronic forms of Borrelia burgdorferi infection of the nervous system. Neurology 1987; 37: 1031-1034.
30. Berglund J, Eitrem R, Ornstein K et al. An epidemiological study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319-1324.
31. White DJ, Chang HG, Benach JL et al. The geographic spread and temporal increase of the Lyme disease epidemic. J Am Med Assoc 1991; 266: 1230-1236.
32. Cutler SJ. Lyme borreliosis: an update. Br J Hosp Infect 1996; 56: 581-583.
33. Livesley MA, Carey D, Gern L, Nuttall PA. Problems of isolating Borrelia burgdorferi from ticks collected in United Kingdom foci of Lyme disease. Med Vet Entomol 1994; 8: 172-178.
34. Guy EC. The laboratory diagnosis of Lyme borreliosis. Rev Med Microbiol 1993; 4: 89-96.
35. Persing DH, Ruledge BJ, Rys PN et al. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis 1994; 169: 668-672.
36. Rahn DW. Lyme disease - where's the bug? N Eng J Med 1994; 330: 282-283.
37. Gerber MA, Shapiro ED, Bell GL, Sampieri A, Padula SJ. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease. J Infect Dis 1995; 171: 724-727.
38. Johnson RC, Kodner C, Russell M. In vitro and in vivo susceptibility of the Lyme disease spirochaete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother 1987; 31: 164-167.
39. Breier F, Kunz G, Klade H, Stanek G, Aberer E. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Infection 1996; 24: 69-72.
40. Weber K. Treatment failure in erythema migrans - a review. Infection 1996; 24: 73-75.
41. Cimmino MA, Moggiana GL, Parisi M, Accardo S. Treatment of Lyme arthritis. Infection 1996; 24: 91-93.
42. Gasser R, Fruhwald F, Schumacher M et al. Reversal of Borrelia burgdorferi associated dilated cardiomyopathy by antibiotic treatment. Cardiovasc Drugs Therapeut 1996; 10: 351-360.
43. Girschick HJ, Huppertz HI, Russmann H, Krenn V, Karch H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int 1996; 16: 125-132.
44. Brouqui P, Badiaga S, Raoult D. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycyclin and erythromycin. Antimicrob Agents Chemother 1996; 40: 1552-1554.
45. Centers for Disease Control. Lyme disease - United States, 1995. MMWR 1996; 45: 481-484.
46. Zhioua E, Aeschlimann A, Gem L. Infection of field-collected Ixodes ricinus (Acari: Ixodidae) larvae with Borrelia burgdorferi in Switzerland. J Med Entomol 1994; 31: 763-766.
47. Obasi OE. Erythema chronicum migrans Br J Dermatol 1977; 97: 459.
48. Goldin D, Champion RH, Rook A, Roberts SCB. Erythema chronicum migrans in Britain. BMJ 1978; 277: 1087.
49. Muhlemann MF, Wright DJM. Emerging pattern of Lyme disease in the United Kingdom and Irish Republic. Lancet 1987; i: 260-262.
50. O'Connell S. Lyme disease in the UK: epidemiology, clinical presentations and diagnosis. J Med Microbiol 1994; 40: 77-78.
51. Bennett CE. Ticks and Lyme Disease. Adv Parasitol 1995; 36: 343-405.
52. Kahl O. Lyme borreliosis - an ecological perspective of a tick-borne human disease. Anz Schadlingsk Pfl- Umwelts 1991; 64: 45-55.
53. Oksi J, Helander I, Aho H, Marjamaki M, Viljanen MK. Borrelia burgdorferi shown by PCR from skin biopsy specimen after a fly bite. In: Axford JS, Rees DHE, eds. Lyme borreliosis. New York: Plenum Press, 1994.
54. Dolan MC, Maupin GO, Panella NA, Golde WT, Piesman J. Vector competence of Ixodes scapularis, I. spinipalpis, and Dermacentor andersoni (Acari: Ixodidae) in transmitting Borrelia burgdorferi, the etiologic agent of Lyme disease. J Med Entomol 1997; 34: 128-135.
55. Angelov L, Dimova P, Berbencova W. Clinical and laboratory evidence of the importance of the tick D. marginatus as a vector of Borrelia burgdorferi in some areas of sporadic Lyme disease in Bulgaria. Eur J Epidemiol 1996; 12: 499-502.
56. Kirstein F, Rijpkema S, Molkenboer M, Gray JS. The distribution and prevalence of B. burgdorferi genomospecies in Ixodes ricinus ticks in Ireland. Eur J Epidemiol 1997; 13: 67-72.
57. Rijpkema SGT, Herbes KG, VerbeekdeKruif N, Schellekens JFP. Detection of four species of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected from roe deer (Capreolus capreolus) in the Netherlands. Epidemiol Infect 1996; 117: 563-566.
58. Gern L, Burgdorfer W, Aeschlimann A, Kramptiz HE. The ecology of Lyme borreliosis in Europe. In: Weber K, Burgdorfer W, eds. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993.
59. Toutoungi LN, Gern L. Ability of transovarially and subsequent transstadially infected Ixodes hexagonus ticks to maintain and transmit Borrelia burgdorferi in the laboratory. Exp Appl Acarol 1993; 17: 581-586.
60. Yeh MT, Bak JM, Hu RJ, Nicholson MC, Kelly C, Mather TN. Determining the duration of Ixodes scapularis (Acari, Ixodidae) attachment to tick-bite victims. J Med Entomol 1995; 32: 853-858.
61. Korenberg EI, Moskvitina GG. Interrelationships between different Borrelia genospecies and their principal vectors. J Vect Ecol 1996; 21: 178-185.
62. Randolph SE, Gem L, Nuttall PA. Co-feeding ticks: epidemiological significance for tick-borne pathogen transmission. Parasitol Today 1996; 12: 472-479.
63. Sato Y, Nakao M. Transmission of the Lyme disease spirochete, Borrelia garinii, between infected and uninfected immature Ixodes persulcatus during cofeeding on mice. J Parasit 1997; 83: 547-550.
64. Talleklint L, Jaenson TGT. Transmission of Borrelia burgdorferi s.l. from mammal reservoirs to the primary vector of Lyme borreliosis, Ixodes ricinus (Acari: Ixodidae), in Sweden. J Med Entomol 1994; 31: 880-886.
65. Battaly GR, Fish D. Relative importance of bird species as hosts for immature Ixodes dammini (Acari: Ixodidae) in a suburban residential landscape of southern New York state. J Med Entomol 1993; 30: 740-747.
66. Miyamoto K, Sato Y, Okada K, Fukunaga M, Sato F. Competence of a migratory bird, red-bellied thrush (Turdus chrysolaus), as an avian reservoir for the Lyme disease spirochetes in Japan. Acta Trop 1997; 65: 43-51.
67. Olsen B, Duffy DC, Jaenson TGT, Gylfe A, Bonnedahl J, Bergstrom S. Transhemispheric exchange of Lyme disease spirochaetes by seabirds. J Clin Microbiol 1995; 33: 3270-3274.
68. McKenna P, Clement J, Vandijck D et al. Canine Lymedisease in Belgium. Vet Rec 1995; 136: 244-247.
69. Talleklint L, Jaenson TGT. Relationship between Ixodes ricinus density and prevalence of infection with Borrelia-like spirochetes and density of infected ticks. J Med Entomol 1996; 33: 805-811.